Management of Heart Failure Patient with CKD.
Banerjee D, Rosano G, Herzog CA.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1131-1139. doi: 10.2215/CJN.14180920. Epub 2021 Jan 25.
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.
Chung MK, Patton KK, Lau CP, Dal Forno ARJ, Al-Khatib SM, Arora V, Birgersdotter-Green UM, Cha YM, Chung EH, Cronin EM, Curtis AB, Cygankiewicz I, Dandamudi G, Dubin AM, Ensch DP, Glotzer TV, Gold MR, Goldberger ZD, Gopinathannair R, Gorodeski EZ, Gutierrez A, Guzman JC, Huang W, Imrey PB, Indik JH, Karim S, Karpawich PP, Khaykin Y, Kiehl EL, Kron J, Kutyifa V, Link MS, Marine JE, Mullens W, Park SJ, Parkash R, Patete MF, Pathak RK, Perona CA, Rickard J, Schoenfeld MH, Seow SC, Shen WK, Shoda M, Singh JP, Slotwiner DJ, Sridhar ARM, Srivatsa UN, Stecker EC, Tanawuttiwat T, Tang WHW, Tapias CA, Tracy CM, Upadhyay GA, Varma N, Vernooy K, Vijayaraman P, Worsnick SA, Zareba W, Zeitler EP.
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS).
Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, Israel C, Joza J, Romero J, Vernooy K, Vijayaraman P, Whinnett Z, Zanon F.
Europace. 2023 Apr 15;25(4):1208-1236. doi: 10.1093/europace/euad043.
Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators.
Iliou MC, Blanchard JC, Lamar-Tanguy A, Cristofini P, Ledru F.
Monaldi Arch Chest Dis. 2016 Oct 14;86(1-2):756. doi: 10.4081/monaldi.2016.756.
Nanostim-leadless pacemaker.
Sperzel J, Hamm C, Hain A.
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):327-333. doi: 10.1007/s00399-018-0598-3. Epub 2018 Oct 19.
Coronary Sinus Lead Positioning.
Roka A, Borgquist R, Singh J.
Heart Fail Clin. 2017 Jan;13(1):79-91. doi: 10.1016/j.hfc.2016.07.007.
Predictors and outcomes of cardiac resynchronization therapy extended to the second generator.
Li X, Yang D, Kusumoto F, Shen WK, Mulpuru S, Zhou S, Liang J, Wu G, Yang M, Liu JQ, Friedman PA, Cha YM.
Heart Rhythm. 2017 Dec;14(12):1793-1800. doi: 10.1016/j.hrthm.2017.09.002. Epub 2017 Sep 14.
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.
Fujiki S, Iijima K, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Shimizu W, Tomita H, Watanabe M, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Hayashi H, Maemura K, Niwano S, Umemoto T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Minamino T; EMPA ICD investigators.
Cardiovasc Diabetol. 2024 Jun 28;23(1):224. doi: 10.1186/s12933-024-02309-9.
Explanting Chronic Coronary Sinus Leads.
Mela T.
Card Electrophysiol Clin. 2019 Mar;11(1):131-140. doi: 10.1016/j.ccep.2018.11.014.
Cardiac resynchronization therapy improves myocardial conduction.
Yang M, Li X, Yang D, Li Y, Zhou S, Liang J, Wu G, Del-Carpio Munoz F, Chen HH, Friedman PA, Cha YM.
Pacing Clin Electrophysiol. 2019 Feb;42(2):238-246. doi: 10.1111/pace.13581. Epub 2018 Dec 27.
